ConductScience.org, home

Paper · 40211787

The molecular landscape of AL amyloidosis.

Zvida-Bloch T and 4 others. Br J Haematol, 2025. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The molecular landscape of AL amyloidosis. Papers, record 40211787. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211787

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The molecular landscape of AL amyloidosis.
PubMed
Journal
Br J Haematol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.66, provisional
iCite
Revised in PubMed
2025-07-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zvida-Bloch TTalhttps://orcid.org/0000-0002-8641-7813
2Muchtar EElihttps://orcid.org/0000-0003-2210-2174
3Dispenzieri AAngela
4Shpilberg OOferhttps://orcid.org/0000-0003-4463-7647
5Hershkovitz-Rokah OOshrathttps://orcid.org/0000-0003-4685-0679

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunoglobulin Light-chain AmyloidosisMajor topic
Humans
Proteomics
Mutation
Transcriptome

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 CA186781NCI NIH HHSUnited StatesP50CA186781PubMed and NIHNIH RePORTER
0005792The Israeli Ministry of Innovation, Science and TechnologyPubMedPubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139,350,582Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee.Amyloid2024https://conductscience.org/library/papers/39350582PubMed
222,100,494Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis.Clin Lymphoma Myeloma Leuk2012https://conductscience.org/library/papers/22100494PubMed
333,431,806Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.Blood Cancer J2021https://conductscience.org/library/papers/33431806PubMed
433,425,465AL Amyloidosis: Unfolding a Complex Disease.J Adv Pract Oncol2019https://conductscience.org/library/papers/33425465PubMed
530,327,369Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma.Blood Adv2018https://conductscience.org/library/papers/30327369PubMed
632,943,087BCMA-targeted immunotherapy for multiple myeloma.J Hematol Oncol2020https://conductscience.org/library/papers/32943087PubMed
728,025,584Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.Leukemia2017https://conductscience.org/library/papers/28025584PubMed
89,447,971Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.Mol Cell Biol1998https://conductscience.org/library/papers/9447971PubMed
930,104,177Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.Clin Lymphoma Myeloma Leuk2018https://conductscience.org/library/papers/30104177PubMed
1027,288,311Does AL amyloidosis have a unique genomic profile? Gene expression profiling meta-analysis and literature overview.Gene2016https://conductscience.org/library/papers/27288311PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42,278,643Multiple Myeloma Concomitant with AL Amyloidosis: Histopathological Aspects of the Common Plasma Cell Spectrum.Int J Mol Sci2026https://conductscience.org/library/papers/42278643PubMed
42,258,481Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.CA Cancer J Clin2026https://conductscience.org/library/papers/42258481PubMed
42,252,535Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.Am J Hematol2026https://conductscience.org/library/papers/42252535PubMed
41,898,891Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications.Genes (Basel)2026https://conductscience.org/library/papers/41898891PubMed
41,309,103[Diagnosis of Amyloidosis in Hand and Plastic Surgery Patients: Optimal Tissue Selection and Examination Methods for Early Detection].Handchir Mikrochir Plast Chir2026https://conductscience.org/library/papers/41309103PubMed
40,211,787The molecular landscape of AL amyloidosis.Br J Haematol2025https://conductscience.org/library/papers/40211787PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40211787

GET https://conductscience.org/api/papers/v1/40211787/references?page=2